Schlumberger NV vs Health Care Select Sector SPDR Fund — how do they compare? Schlumberger NV trades at $46.77 (market cap $69.36B), while Health Care Select Sector SPDR Fund trades at $160.31. The key difference: Schlumberger NV pays a 2.54% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Schlumberger NV nearer its low. Which is the better fit depends on your goals.
| SLB | XLV | |
|---|---|---|
Market Cap | $69.36B | — |
Sector | Energy | — |
52-Week High | $58.01 | $164.48 |
52-Week Low | $31.72 | $129.01 |
Enterprise Value | $77.58B | — |
Dividend Yield | 2.54% | — |
Signals from Pluang's Aura AI — not financial advice
SLB trades at $46.59, down 0.85% on the day, with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with a 9.26% net margin and 14.57% ROE, supported by $6.5B in operating cash flow. Recent strategic moves include a partnership with Liberty Energy for data center power solutions and major contract wins like the Baleine Phase 3 EPC award, positioning SLB to capitalize on energy and AI infrastructure demand.
The outlook is cautiously optimistic with an 84.85% analyst buy rating and a $62.83 consensus price target implying 35% upside. Risks include oil price volatility and execution challenges in new ventures, but SLB's solid balance sheet and digital growth initiatives offer a compelling case for long-term investors amid near-term market weakness.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →